BeStock  
Stocks › AXSM

Axsome Therapeutics AXSM

US equityMarket cap rank #1751
$129.36 −$6.32 (-4.66%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $129.36 0.00%
Open$133.92
Prev close$135.68
Day range$128.23 – $135.09
Volume811.8K
Market cap$6.80B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±4.7%last 16 reports
Closed higher9 of 1656% of the time
Best reaction+9.4%
Worst reaction-12.6%

Stock move on the day after each report

-12.6%2023/Q4+1.5%2024/Q1-1.4%2024/Q2+9.4%2024/Q3-2.3%2024/Q4+3.8%2025/Q1+3.4%2025/Q2+0.6%2025/Q3-4.9%2025/Q4+8.3%2026/Q1+3.8%2026/Q2-5.8%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q32 Nov 2026Pre Market±13.4%-5.83%Within range
2026/Q210 Aug 2026Pre Market±8.8%+3.83%Within range
2026/Q14 May 2026Pre Market±6.0%+8.31%Bigger than priced
2025/Q423 Feb 2026Pre Market±7.6%-4.88%Within range
2025/Q33 Nov 2025Pre Market±7.5%+0.56%Within range
2025/Q24 Aug 2025Pre Market±8.9%+3.42%Within range
2025/Q15 May 2025Pre Market±9.4%+3.81%Within range
2024/Q418 Feb 2025Pre Market±7.7%-2.33%Within range
2024/Q312 Nov 2024Pre Market±9.8%+9.35%Within range
2024/Q25 Aug 2024Pre Market±11.2%-1.43%Within range
2024/Q16 May 2024Pre Market±9.4%+1.52%Within range
2023/Q420 Feb 2024Pre Market±12.7%-12.57%Within range
2023/Q36 Nov 2023Pre Market±9.2%-4.18%Within range
2023/Q27 Aug 2023Pre Market±8.7%-3.49%Within range
2023/Q18 May 2023Pre Market±10.6%+5.41%Within range
2022/Q427 Feb 2023Pre Market±13.9%+4.96%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q3

By business line

  • AUVELITY$207.61M 79.9%
  • Sunosi$38.45M 14.8%
  • SUNOSI milestone revenue$8.51M 3.3%
  • Symbravo$3.89M 1.5%
  • SUNOSI royalty revenue$1.23M 0.5%

Latest reported quarter: Q3, ended Sep 2026

Revenue$259.69M+51.9% YoY
Operating profit-$13.45M+59.2% YoY
Net profit-$12.88M+72.7% YoY
Diluted EPS-$0.25+73.4% YoY
Free cash flow-$9.67M-1,078.3% YoY
Operating cash flow-$9.47M

Revenue, last 8 quarters

$118.8MDec '24$121.5MMar '25$150.0MJun '25$171.0MSep '25$196.0MDec '25$191.2MMar '26$218.4MJun '26$259.7MSep '26

Net profit, last 8 quarters

$-74.9MDec '24$-59.4MMar '25$-48.0MJun '25$-47.2MSep '25$-28.6MDec '25$-64.5MMar '26$-51.3MJun '26$-12.9MSep '26

Profitability & balance sheet

Gross margin93.2%
Operating margin-18.9%
Net margin-18.2%
Return on equity-175.6%
Return on assets-21.0%
Return on invested capital-49.5%
Current ratio1.42
Liabilities / assets87.2%
Cash & investments$313.86M
Total debt$218.01M
Net cash (debt)$95.85M

Discussion

No comments yet — be the first to weigh in on AXSM.

Sign in to join the discussion.

Scroll to Top